Crossmark

A randomized controlled trial of an mHealth intervention for increasing access to HIV testing and care among young cisgender men and transgender women: the mLab App study protocol

Crossref DOI link: https://doi.org/10.1186/s12889-021-12015-w

Published Online: 2021-10-29

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wood, Olivia R.

Garofalo, Robert

Kuhns, Lisa M.

Scherr, Thomas F.

Zetina, Ana Paola Mata

Rodriguez, Rafael Garibay

Nash, Nathanael

Cervantes, Marbella

Schnall, Rebecca https://orcid.org/0000-0003-2184-4045
Funding

Funding for this research was provided by:

National Institute of Mental Health (R01MH118151)

National Institute of Nursing Research (K24NR018621)
License Information

Text and Data Mining valid from 2021-10-29

Version of Record valid from 2021-10-29
More Information

Article History

Received: 5 October 2021

Accepted: 15 October 2021

First Online: 29 October 2021

Declarations

:

: Prior to beginning data collection, all participants provide written informed consent (before the onset of COVID-19) and oral informed consent (after the onset of COVID-19 and for the duration of the study). All study procedures were approved by the Columbia University Medical Center Institutional Review Board (IRB) and Robert H. Lurie Children’s Hospital of Chicago Institutional Review Board (IRB).

: N/A

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below